Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Indian diabetic population on Human Mixtard concerned on changes in insulin therapy: Nandita Vijayasimha, Bengaluru Thursday, April 24, 2025, 08:00 Hrs [IST] India’s diabetic po ...

In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...

ideal for patients afraid of injections The approval marks a significant milestone in India’s healthcare, offering a new way to manage blood sugar levels efficiently Afrezza (Insulin Human ...

The idea is to supplement this protein with a subcutaneous injection ... process for human testing in 2025. Current diabetes research has mainly focused on improving insulin sensitivity—how ...

I’m an old dog. There’s no denying it. I like to do things the way I have always done them. But I also like to keep current ...

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

Feline diabetes mellitus (DM) is currently understood to have strong similarities to human type 2 diabetes. Veterinarians ...